Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bioengineered foods

This article was originally published in The Tan Sheet

Executive Summary

A proposed rule requiring developers to notify FDA at least 120 days before marketing bioengineered foods is in the works, the agency announces May 3. FDA will require specific data be submitted to help determine whether the foods pose any potential safety, labeling or adulteration issues. After reviewing the company's submission, the agency will issue a letter stating its conclusions about the foods' regulatory status. Guidance on voluntary labeling to highlight the inclusion or absence of bioengineered food ingredients also is part of FDA's strategy. The proposals could affect the dietary supplement and functional foods sectors, particularly with regard to use of genetically modified soybeans
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS091174

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel